Download the pdf brochure - 1 Mo

Welcome Address

Vimont H.E. Pierre VIMONT
Ambassador of France to the United States
Welcome address
Braunwald Dr. Eugene BRAUNWALD
Distinguished Hersey Professor of Medicine at Harvard Medical School, and Chairman of the TIMI Study Group at the Brigham and Women’s Hospital, Boston, USA
Introductory adress

Pr. Christian BRECHOT
Executive Director of Inserm, Paris, France
Introductory lecture

Keynote Speaker

Libby Dr. Peter LIBBY
Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital, Boston, USA
Keynote Lecture "Pathophysiology of atherothrombosis"



Dr. Zahi FAYAD
Director, Sinai Translational and Molecular Imaging Institute, NewYork, USA


Director of Translational Research in the Cardiology Division at the Massachusetts General Hospital. Associate Professor of Medicine at Harvard Medical School and a Senior Associate at the Broad Institute of Harvard and MIT, Boston, USA


Dr. Farouc JAFFER
Director of Vascular Imaging in the Cardiovascular Molecular Imaging Program at Massachusetts General Hospital, Harvard Medical School. Attending Interventional Cardiologist at Massachusetts General Hospital, Boston, USA
Molecular Imaging


Dr. Xavier JOUVEN
Cardiologist and electrophysiologist at the European G. Pompidou Hospital in Paris and an epidemiologist in Villejuif (INSERM U780) - Inserm, France
Sudden Cardiac Death: Identification of risk factors for sudden cardiac death in the population


Dr. Michael T. KLIMAS
Executive Director, Franchise Imaging Lead, Merck Research Laboratories, Boston, USA

Lancelot Dr. Eric LANCELOT
Manager of the Biology Research Department of GUERBET, a French company specialized in the research, development and production of contrast media for medical imaging. Roissy, France
Development of contrast agents for molecular magnetic resonance imaging of vulnerable atherosclerotic plaques
Lee Dr. Richard LEE
Associate Professor of Medicine at Harvard Medical School and in Health Sciences and Technology at MIT and lecturer in Biological Engineering at MIT, Boston, USA
Markers of Mechanical Stress
Mallat Dr. Ziad MALLAT
Director of Research at Inserm, Paris, France.
Montalescot Pr.Gilles MONTALESCOT
Professor of Cardiology at Pitié-Salpétrière Hospital, Paris, France.
Stable Atherosclerosis. Platelet function
Morrow Dr. David MORROW
Assistant Professor of Medicine at Harvard Medical School, in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital, Boston, USA
Ridker Dr. Paul RIDKER
Professor of Medicine, Harvard Medical School. Director, Center for Cardiovascular Disease Prevention
Divisions of Cardiovascular Diseases and Preventive Medicine, Brigham and Women’s Hospital, Boston, USA
Rifai Dr. Nader RIFAI
Professor of Pathology at Harvard Medical School and the Louis Joseph Gay-Lussac Chair in Laboratory Medicine and the Director of Clinical Chemistry at Children’s Hospital, Boston, USA
Rioufol Dr. Gilles RIOUFOL
Associate Professor in cardiology, specializing in interventional cardiology, and researcher in the Inserm unit EMI-U 0226, Lyon, France
Can IVUS help to detect the evolution of vulnerable plaque
Sabatine Dr. Marc SABATINE
Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and Assistant Professor of Medicine at Harvard Medical School and the Cardiovascular Medicine Division at Brigham and Women’s Hospital, Boston, USA
Acute Coronary Syndromes

Dr. Alain TEDGUI
Scientific Coordinator of the first European Network of Excellence in the field of vascular biology and medicine, the European Vascular Genomics Network (EVGN), Inserm, APHP, France
Stable Atherosclerosis. Microparticules, and other Lipid-related markers.
Molecular imaging with oligonucleotides

Tiret Dr. Laurence TIRET
Director of Research at the French Institute for Medical Research, Inserm, Paris, France
Genetics of cardiovascular diseases - From single mutations to the whole genome
Zannad Pr. Faiez ZANNAD
Professor of Therapeutics at the Medical Faculty of the Henri Poincaré University of Nancy, Inserm, Hôpital Central, Nancy, France
Fibrosis Markers in Heart Failure. Trials and treatment